Resistance of R-Ras knockout mice to skin tumour induction
May, Ulrike; Prince, Stuart; Vähätupa, Maria; Laitinen, Anni M; Nieminen, Katariina; Uusitalo-Järvinen, Hannele; Järvinen, Tero AH (2015)
May, Ulrike
Prince, Stuart
Vähätupa, Maria
Laitinen, Anni M
Nieminen, Katariina
Uusitalo-Järvinen, Hannele
Järvinen, Tero AH
2015
Scientific Reports 5
11663
Lääketieteen yksikkö - School of Medicine
Julkaisun pysyvä osoite on
https://urn.fi/URN:NBN:fi:uta-201608042134
https://urn.fi/URN:NBN:fi:uta-201608042134
Tiivistelmä
The R-ras gene encodes a small GTPase that is a member of the Ras family. Despite close sequence similarities, R-Ras is functionally distinct from the prototypic Ras proteins; no transformative activity and no activating mutations of R-Ras in human malignancies have been reported for it. R-Ras activity appears inhibitory towards tumour proliferation and invasion, and to promote cellular quiescence. Contrary to this, using mice with a deletion of the R-ras gene, we found that R-Ras facilitates DMBA/TPA-induced skin tumour induction. The tumours appeared in wild-type (WT) mice on average 6 weeks earlier than in R-Ras knockout (R-Ras KO) mice. WT mice developed almost 6 times more tumours than R-Ras KO mice. Despite strong R-Ras protein expression in the dermal blood vessels, no R-Ras could be detected in the epidermis from where the tumours arose. The DMBA/TPA skin tumourigenesis-model is highly dependent upon inflammation, and we found a greatly attenuated skin inflammatory response to DMBA/TPA-treatment in the R-Ras KO mice in the context of leukocyte infiltration and proinflammatory cytokine expression. Thus, these data suggest that despite its characterised role in promoting cellular quiescence, R-Ras is pro-tumourigenic in the DMBA/TPA tumour model and important for the inflammatory response to DMBA/TPA treatment.
Kokoelmat
- Artikkelit [6140]